Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity

NCT04114903 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.

NCT NCT04114903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04114903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
Lead sponsor
University of Colorado, Boulder
Phase
Observational
Overall status
Completed
Start date
November 8, 2019
Completion date
December 1, 2024
Enrollment
233 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use, insulin sensitivity, obesity, type 2 diabetes